Sotera Health Company (SHC) Income Statement
SHC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSHC revenue and net income
Where SHC's revenue goes
2025Each bar shows an amount and its share of revenue. SHC kept 6.7% of revenue as net income.
SHC profit margins
SHC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +5.7% | +5.1% | +7.3% | — |
| Gross profit | +7.2% | +5.0% | +7.8% | — |
| Operating income | +32.0% | +16.5% | +13.8% | — |
| Net income | +75.6% | — | — | — |
| EPS (diluted) | +22.9% | −3.9% | +48.3% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SHC quarterly EPS vs estimates
Sotera Health beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 3, 2026 (estimate $0.24).
SHC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.5M | $818.2M | $778.3M | $746.1M |
| Cost of revenue | $518.1M | $498.1M | $472.1M | $446.7M | $412.8M | $374.6M | $382.9M | $388.9M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M | $443.6M | $395.4M | $357.3M |
| Sales, general & admin | $252.8M | $242.6M | $242.3M | $245.7M | $198.2M | $178.5M | $147.5M | $133.4M |
| Total operating expenses | $252.8M | $304.7M | $300.5M | $308.7M | $261.9M | $237.6M | $211.8M | $191.3M |
| Operating income | $392.8M | $297.6M | $276.7M | $248.3M | $256.7M | $206.0M | $183.6M | $80.8M |
| Interest expense | $155.7M | $164.7M | $142.9M | $80.1M | $74.2M | $215.3M | $157.7M | $143.3M |
| Income before taxes | $147.5M | $113.9M | $106.0M | −$243.1M | $175.7M | −$38.9M | −$916,000 | $24.2M |
| Income taxes | $69.6M | $69.5M | $54.7M | −$9.5M | $58.6M | −$1.4M | $19.5M | $30.1M |
| Net income | $77.9M | $44.4M | $51.4M | −$233.6M | $116.9M | −$38.6M | −$20.9M | −$5.9M |
| EBITDA | $442.3M | $442.2M | $406.8M | −$17.4M | $400.8M | $320.0M | $303.5M | $314.4M |
| EPS (diluted) | $0.86 | $0.70 | $0.81 | $0.97 | $0.88 | $0.12 | $0.01 | $0.03 |
| Gross margin | 55.5% | 54.7% | 55.0% | 55.5% | 55.7% | 54.2% | 50.8% | 47.9% |
| Operating margin | 33.8% | 27.0% | 26.4% | 24.7% | 27.6% | 25.2% | 23.6% | 10.8% |
| Net margin | 6.7% | 4.0% | 4.9% | −23.3% | 12.5% | −4.7% | −2.7% | −0.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.4M | $280.0M | $303.4M | $311.3M | $294.3M | $254.5M | $290.2M | $285.5M | $276.6M | $248.2M | $310.2M | $263.2M |
| Cost of revenue | $143.4M | $136.0M | $137.5M | $133.8M | $127.7M | $119.1M | $125.8M | $127.4M | $123.8M | $121.1M | $130.2M | $117.2M |
| Gross profit | $178.0M | $144.0M | $165.9M | $177.6M | $166.6M | $135.4M | $164.4M | $158.0M | $152.8M | $127.1M | $180.1M | $146.0M |
| Sales, general & admin | $68.2M | $68.2M | $57.5M | $63.3M | $68.9M | $63.1M | $61.8M | $62.0M | $60.6M | $58.2M | $60.4M | $54.1M |
| Total operating expenses | $71.2M | $57.4M | $29.8M | $66.4M | $78.2M | $78.4M | $77.2M | $77.5M | $76.0M | $73.9M | $76.1M | $69.9M |
| Operating income | $106.8M | $86.6M | $136.1M | $111.2M | $88.4M | $57.0M | $87.1M | $80.5M | $76.8M | $53.2M | $104.0M | $76.1M |
| Interest expense | $34.4M | $34.7M | $35.0M | $39.1M | $40.7M | $40.9M | $41.0M | $41.6M | $40.4M | $41.8M | $42.7M | $40.6M |
| Income before taxes | $78.1M | $42.6M | $70.5M | $72.9M | $18.9M | −$14.8M | $45.0M | $42.8M | $15.1M | $11.0M | $65.7M | $470,000 |
| Income taxes | $24.4M | $16.0M | $35.6M | $24.5M | $10.9M | −$1.6M | $32.6M | $25.8M | $6.4M | $4.7M | $27.0M | $14.1M |
| Net income | $53.6M | $26.6M | $34.8M | $48.4M | $8.0M | −$13.3M | $12.3M | $17.0M | $8.8M | $6.3M | $38.7M | −$13.7M |
| EBITDA | $145.9M | $108.2M | $138.1M | $140.4M | $95.2M | $66.9M | $126.2M | $127.4M | $95.4M | $93.2M | $149.0M | $79.3M |
| EPS (diluted) | $0.24 | $0.18 | $0.26 | $0.26 | $0.20 | $0.14 | $0.21 | $0.17 | $0.19 | $0.13 | $0.26 | $0.21 |
| Gross margin | 55.4% | 51.4% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% | 55.2% | 51.2% | 58.0% | 55.5% |
| Operating margin | 33.2% | 30.9% | 44.9% | 35.7% | 30.0% | 22.4% | 30.0% | 28.2% | 27.8% | 21.4% | 33.5% | 28.9% |
| Net margin | 16.7% | 9.5% | 11.5% | 15.5% | 2.7% | −5.2% | 4.2% | 6.0% | 3.2% | 2.5% | 12.5% | −5.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SHC's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SHC financial results
In fiscal year 2025 (ended December 31, 2025), Sotera Health reported revenue of $1.2 billion, up 5.7% from the year before. It had net income of $77.9 million (up 75.6%), a net profit margin of 6.7%. Diluted earnings per share came to $0.86. Over five years revenue grew at an average rate of 7.3% a year.
See the SHC stock overview for the latest quote and news, or the SHC chart for price history and technical indicators.
SHC income statement FAQ
What is Sotera Health's annual revenue?
Sotera Health reported total revenue of $1.2 billion for fiscal year 2025, which ended on December 31, 2025. That was up 5.7% from $1.1 billion the previous year.
Is Sotera Health profitable?
Yes. Sotera Health reported net income of $77.9 million in fiscal 2025, a net profit margin of 6.7%; its operating margin was 33.8%.
What is Sotera Health's gross margin?
Sotera Health's gross margin was 55.5% in fiscal 2025: for every $100 of revenue, Sotera Health kept $55 after the direct cost of its products and services.
How fast is Sotera Health growing?
Revenue grew 7.3% a year on average over the last five fiscal years, from $818.2 million to $1.2 billion.
What are Sotera Health's earnings per share?
Sotera Health earned $0.86 per diluted share in fiscal 2025, compared with $0.70 a year earlier.
When will Sotera Health report its next earnings?
Sotera Health is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens.
When does Sotera Health's fiscal year end?
Sotera Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.